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TIP60 regulation of DNp63a is associated with Cisplatin resistance 
Akshay Hira1, Andrew J. Stacy1, Jin Zhang1, Michael Craig1, and Madhavi P. Kadakia1
1Department of Biochemistry and Molecular Biology, Wright State University, Colonel Glenn Hwy, Dayton, OH 45435 
Abstract 
ΔNp63α, a member of the p53 transcription factor family, is overexpressed in non-melanoma skin cancer and 
regulates cell survival, migration and invasion. TIP60 is histone acetyltransferase (HAT) which mediates cellular 
processes such as transcription and the DNA damage response (DDR). Since ΔNp63α is known to transcriptionally 
regulate several DDR genes and promote cisplatin resistance, its stabilization by TIP60 may contribute to the failure 
of platinum-based drugs in squamous cell carcinoma (SCC). We hypothesize that TIP60 regulates the transcriptional 
activity of ΔNp63α thereby modulating chemoresistance. In this study, we showed that overexpression of TIP60 in 
both H1299 and A431 cells led to increase in the levels of ΔNp63α, while TIP60 silencing in A431 cell lines led to a 
decrease in endogenous ΔNp63α transcript and protein levels, thus confirming that TIP60 positively regulates 
ΔNp63α in these cell lines. Increased levels of ΔNp63α and TIP60 were observed in a cisplatin resistant A431 SCC 
line. Further, stable expression of TIP60 or ΔNp63α individually promoted resistance to cisplatin, whereas loss of 
ΔNp63α and TIP60 sensitized cells to cisplatin. Higher acetylation of ΔNp63α and TIP60 were seen in cisplatin 
resistant cells. Taken together, our data suggest that TIP60-mediated regulation of ΔNp63α increases cisplatin 
resistance and has potential implications for cancer treatment and drug design. Additionally, since ΔNp63α confers 
cisplatin resistance through regulation of genes involved in DNA damage repair, our findings provide critical insight 
into the mechanism by which genes involved in cisplatin resistance are regulated and may lead to strategies for 
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Figure 1: p63 isoforms. Schematic of the p63 gene comprising of the two promoter sites, 3’ splicing segments, and 
the resulting six main p63 isoforms (TAp63α, TAp63β, TAp63γ, ΔNp63α, ΔNp63β and ΔNp63γ). The domains are as 
follows: transactivation domain (TA), DNA-binding domain (DBD), oligomerization domain (OD), sterile alpha motif 
(SAM), and transactivation inhibitory domain (TI). 
TIP60- a histone acetyltransferase 














Figure 2: TIP60. Schematic of the TIP60 protein comprising of the domains as follows: Chromodomain, Zinc finger 
motif (Zn Finger), Histone acetyltransferase domain (HAT domain) and Nuclear receptor box (NR box). The MYST 
domain, comprised of an acetyl-coenzyme A binding domain and a zinc finger motif, is responsible for catalytic 
activity. 












Figure 3: Potential mechanisms by which TIP60 regulates ΔNp63α. 
TIP60 silencing reduces ΔNp63α transcript and protein levels 
B. 
Figure 4: TIP60 silencing reduces ΔNp63α transcript and protein levels. A431 cells were transfected with non-
silencing control (NSC) siRNA or siRNA against p63 (sip63) and/or TIP60 (siTIP60) and harvested at 48 hours post-
transfection. (A) RNA levels were measured by TaqMan based qRT-PCR with assays on demand (AOD’s) specific 
to ΔNp63α, TIP60 and normalized to GAPDH. Fold-changes are calculated relative to NSC. Error bars represent ±1 
standard deviation from the mean. *P<0.05 compared to respective NSC control. (B) Protein levels were measured 
by immunoblot analysis performed with antibodies specific for p63, TIP60 or β-actin. β-actin was included as a 
loading control for equivalent protein in each lane. 
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Figure 4: Cisplatin resistant cells exhibit elevated levels of TIP60 and ΔNp63α. (A) A431 Parental (control) and 
Pt (cisplatin-resistant) cells were subjected to a 2 hr cisplatin pulse using increasing concentrations of cisplatin. At 48 
h post-treatment, cell viability was measured by MTS assay. The y-axis indicates fold change compared to vehicle 
treated cells. Error bars represent ±1 standard deviation from the mean value of two representative experiments. 
*P<0.05 compared to parental A431 at the same cisplatin dose (B) Immunoblot analysis performed on A431 parental
and Pt cells using antibodies specific for ΔNp63α, TIP60 or β-actin. Immunoblot with β-actin was performed to
confirm equivalent protein loading. Densitometry quantitation of protein levels relative to Parental cell vehicle controls
is indicated.
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Figure 5:Overexpression of TIP60 protects ΔNp63α levels upon Cisplatin treatment. (A,B) Lenti-A431 e-GFP 
and Lenti-A431-TIP60 stable cells were treated with either DMSO (vehicle) or at two cisplatin dosage in a 2-hours 
pulse and harvested 24 hours later. Immunoblot analysis was performed using antibodies specific to ΔNp63α, TIP60, 
eGFP or β-actin. Immunoblot with β-actin was performed to confirm equivalent protein loading. 
Silencing of TIP60 and/or ΔNp63α sensitizes cells to cisplatin 
Figure 6: Silencing of TIP60 and/or ΔNp63α sensitizes Pt cells to cisplatin. A431 Parental (control) and cisplatin-
resistant (Pt) cells were transfected with non-silencing control (NSC) siRNA or siRNA against p63 (sip63) or TIP60 
(siTIP60) followed by treatment with a 2-hour pulse of vehicle at the indicated cisplatin doses. Cell viability was 
measured by MTS assay at 48 hours. The y-axis indicates the fold change compared to vehicle treated cells. Error 
bars represent ±1 standard deviation from the mean. 
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Figure 7: Stable expression of either ΔNp63α or 
TIP60 increases resistance to cisplatin. Lenti-A431-
eGFP (control), ΔNp63α and TIP60 were subjected to a 
2-hour cisplatin pulse treatment at the indicated doses.
Cell viability was measured by MTS assay at 24 hours.
The y-axis indicates fold change compared to the
vehicle treated cells. Error bars represent ±1 standard
deviation from the mean of two representative
experiments.
Acetylation of ΔNp63α is elevated in cisplatin resistant cells 
Figure 8: Acetylation of ΔNp63α is 
elevated in cisplatin resistant Pt cells. 
A431 Parental (control) and cisplatin-
resistant (Pt) cells were treated with 30mM 
sodium butyrate and 250µM of Acetyl-CoA 
for 6 hours and harvested 6 hours post 
treatment. Whole cell lysates were 
immunoprecipitated (IP) with an 
acetylated-lysine antibody followed by 
immunoblot analysis using antibodies 
















• Cisplatin resistant cells exhibit elevated levels of TIP60 and ΔNp63α
• TIP60 protects ΔNp63α upon Cisplatin treatment
• Silencing of TIP60 and/or ΔNp63α sensitizes cells to cisplatin
• ΔNp63α/TIP60 expression increase resistance to cisplatin
• Acetylation of ΔNp63α is elevated in cisplatin resistant cells
Future Directions 
• Confirm acetylation of ΔNp63α is dependent on Tip60 in cisplatin resistant cells
• Validate the finding from NGS study
• Study the effects of TIP60 on ΔNp63α transcriptional activity
• Identify the genes differentially regulated by ΔNp63α in DNA damage response
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